NCT01199978View on ClinicalTrials.gov

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 8, 2011

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Vestibular SchwannomaAcoustic Neuroma
Interventions
RADIATION

Fractionated proton radiation

Given daily for approximately 5.5 weeks

DRUG

Losartan

25mg or 50mg daily, oral administration, for approximately 6 months.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER